实体器官移植患者术后结核感染的分析

Tuberculosis infection in solid organ transplantation recipients after surgery

  • 摘要: 目的 总结实体器官移植(SOT)患者术后结核感染的临床特点、诊断及治疗难点,同时探讨其解决方案。方法 回顾性分析2002年2月-2015年10月于医院移植研究所进行实体器官(肝脏及肾脏)移植术后发生结核感染38例患者的临床资料,分析其临床症状、体征、实验室及影像学等辅助检查结果、治疗方案选择及预后情况。结果 共调查3 093例患者,术后发生结核感染38例,感染率为1.23%;抗结核治疗过程中,出现较多的不良反应为肝损害和消化系统症状,分别占18.4%、13.2%;发生结核感染患者经过个体化治疗,随访1~108个月,29例患者治愈、2例患者在治、6例死亡、1例患者失访,死亡患者中1例死于肿瘤复发,2例死于结核播散,2例死于肝功能衰竭,1例死于感染性休克。结论 实体器官移植患者术后结核感染率高,进展快,临床表现不典型,诊断和治疗上存在很多难点,需根据患者的移植器官及其肝肾功能选择治疗方案,必要时需对患者进行诊断性治疗。

     

    Abstract: OBJECTIVE To summarize the clinical feature, difficulties in diagnosis and treatment,and solutions of tuberculosis infection in post-solid organ transplantation patients. METHODS The clinical data of 38 patients with TB who occurring among SOT in organ transplant institution from Feb. 2002 to Oct. 2015 were retrospectively reviewed, and the clinical manifestations, laboratory and radiological results, treatment programs and prognosis were analyzed. RESULTS Thirty eight of 3093 SOT recipients developed TB, with the infection rate of 1.23%. The most frequent adverse reactions in anti-TB treatment were respectively liver damage(18.4%) and gastrointestinal symptoms (13.2%). Each patient was adopted with individual treatment. The following up were 1 month to 108 months. Twenty-nine cases were cured, 2 cases were being treated, 1 case was lost to follow-up, and 6 cases died, including 1 case died of tumor recurrence, 2 cases died of disseminated tuberculosis, 2 cases died of liver failure, and 1 case died of septic shock. CONCLUSION SOT recipients with a high incidence of TB, rapid development, clinical manifestations are not typical, and there are many difficulties in diagnosis and treatment. The treatment strategies should be chosen according to the transplantation organs and liver and kidney function. Diagnostic therapy against tuberculosis should be put into practice for the patients with suspicious tuberculosis.

     

/

返回文章
返回